Zoetis (ZTS) Minority Interest (2012 - 2024)
Zoetis' (ZTS) quarterly Minority Interest came in at -$6.0 million in Q2 2024, down 50.0% year-on-year from -$12.0 million in Q3 2023, and little changed on a QoQ basis from -$6.0 million in Q1 2024.
Zoetis (ZTS) Minority Interest (2012 - 2024) Analysis & Trends
Zoetis (ZTS) has 12 years of Minority Interest data on file, last reported at -$6.0 million in Q2 2024.
- On a quarterly basis, Minority Interest fell 50.0% year-over-year to -$6.0 million in Q2 2024; TTM through Jun 2024 was -$6.0 million, a 50.0% decrease from a year earlier, with the FY2023 full-year figure at -$6.0 million, down 200.0% from the prior year.
- Minority Interest for Q2 2024 stood at -$6.0 million, roughly flat from -$6.0 million in the prior quarter.
- Over the last five years, Minority Interest for ZTS reached as high as $5.0 million in Q2 2020 and fell as low as -$6.0 million in Q4 2023.
- Historically, Minority Interest has averaged -$666666.7 across 5 years, with a median of -$1.0 million in 2022.
- Across the five-year window, Minority Interest slumped 300.0% in 2022 and slumped 50.0% in 2024, its largest moves.
- Year by year, Minority Interest stood at $4.0 million in 2020, then slumped by 75.0% to $1.0 million in 2021, then slumped by 300.0% to -$2.0 million in 2022, then slumped by 200.0% to -$6.0 million in 2023, then changed by 0.0% to -$6.0 million in 2024.
- Per Business Quant data, the three most recent Minority Interest figures were -$6.0 million in Q2 2024, -$6.0 million in Q1 2024, and -$6.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -6.00 Mn |
| Mar 31, 2024 | -6.00 Mn |
| Dec 31, 2023 | -6.00 Mn |
| Sep 30, 2023 | -4.00 Mn |
| Jun 30, 2023 | -4.00 Mn |
| Mar 31, 2023 | -3.00 Mn |
| Dec 31, 2022 | -2.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 2.00 Mn |
| Jun 30, 2021 | 2.00 Mn |
| Mar 31, 2021 | 3.00 Mn |
| Dec 31, 2020 | 4.00 Mn |
| Sep 30, 2020 | 5.00 Mn |
| Jun 30, 2020 | 5.00 Mn |
| Jun 30, 2018 | 12.00 Mn |
| Mar 31, 2018 | 15.00 Mn |
| Dec 31, 2017 | 16.00 Mn |
| Oct 1, 2017 | 30.00 Mn |
| Jul 2, 2017 | 31.00 Mn |